Dan Shelly Email & Phone Number

Chief Business Development Officer @ Immuthera

View Dan's Email & Phone Number

5 free lookup(s).

If you need more lookups, subscriptions start at $34 USD/month.

Dan Shelly Location

Cincinnati, OH, US

Dan Shelly Work

Chief Business Development Officer @ (June 2025 - Present)
Chief Business Development Officer @ (February 2024 - Present)
Board of Directors - BioSolutions Designs @ (January 2021 - Present)
Scientific Advisory Board Member @ (January 2021 - January 2025)
Vice President Business Development and Alliances @ (November 2020 - February 2024)
Director Global Business Development and Strategic Partnerships, Essential Medicines @ PATH (October 2019 - November 2020)
Director Business Development @ (January 2016 - November 2020)
Director Business Development @ (June 2011 - January 2016)
Director, Business Development @ (February 2004 - June 2011)
Sr. Regulatory Affairs Specialist @ Kendle International (January 2001 - December 2003)
Sr. Regulatory Affairs Specialist @ Kendle International (January 2001 - January 2003)
Consultant @ Emerging Concepts Inc (January 1999 - January 2001)

Dan Shelly Education

University of Cincinnati Carl H. Lindner College of Business
MBA (Innovation)
2000-2002
University of Cincinnati College of Medicine
Post Doctoral Fellow (Molecular Physiology)
1997-2001
Florida State University
PhD (Molecular Physiology)
1993-1997
William & Mary
MA (Physiology)
1991-1994
Lehigh University
BS (Biology)
1987-1991

Dan Shelly Skills

Biotechnology
Biopharmaceuticals
Life Sciences
Lifesciences
Vaccines
Drug Development
Pharmaceutical Industry
Medical Devices
Clinical Development
Biologics
Infectious Diseases
Protein Chemistry
GMP
Immunology
Regulatory Affairs
Contract Negotiation
Genomics
Clinical Trials
New Business Development
Commercialization
Clinical Research
Immunoassays
Drug Delivery
Antibodies
Oncology
GLP
Key Account Management
Cell
cGMP
Mentoring
Problem Solving
Controled Release
Half-life Extension
Valuation
Pharmaceuticals
Leadership
Business Strategy
Mergers & Acquisitions
Cross-functional Team Leadership
Strategic Planning
Strategic Partnerships
Business Development
Medical Diagnostics
Administrative Assistance
Financial Advisory
Vascular
Consulting
Market
Surgery
A2
Animal Behavior
Sales
Undergraduate
Strain
Cost
Students
Astra
Netherlands
Competitive Analysis
Finance
Hon
Coupling
Recognizing
Invention
31p
Induction
Pii
Ivig
Dec Alpha
Symposium
Contract Manufacturing
Entrepreneurship
SEP IRA
Particle
APIs
RNA
Mammalian
Location Intelligence
Cross Functional Team Leadership
Facilitation
Co Authored
Wet
Nih
Controlled Release
Disease
Cancer
Florida
Acid
Meridian
Cda
Article
Management
Die
Design
Evening
Feasibility Studies
Peptides
Jamaica
Science
Physiology
Cellular Communications
Grads
Corporate Actions
Cell Physiology
Half Life Extension
Stimulation
Newborn
Mouse
Medicaid
Anatomy
Lung
Genetic Engineering
APS
Gel
Boston
Publications
Respiration
Conjugation
Finalist
Execution
Executive Education
Fusion
Dosing
Construct
Consumer
Foundation
Biodefense
System
Lightning
Business Services
Data Recovery
PCR
Rebranding
Enzyme Activity
Utilization
Radio Access Network
Baltimore
Vps
KnockoutJS
Strategy
Muscle
Organizational Restructuring
Human Anatomy
Strategies
Budgeting
Pathology
Medicine
Design Teams
Ablation
GCP
Training
Calculations
News
Diabetes
Solution
Conferences
Business Management
Virus
Protein Expression
Project Management
Thermal
American
Research
Emerging Technologies
Graduate Students
Cloning
Isometric
Transgenic Mice
Investigation
Chicago
Analysis
Partnerships
Molecular
Abstracts
Hospitals
Raps
Zoology
Bioprocessing
Laboratory
Concepts
Autoimmunity
R
Microsurgery
Metabolism
Tall
Economy
Ion
C
Instrumental
Western Blotting
Immunogenicity
Recombinant Dna
FIX Protocol
Market Planning
Fearless
Applications
Tissue
Managerial Finance
IV
DNA
Evidence
Cell Culture
Baculovirus
Energy
Safety
Characterization
Licensing
Operations
Stage
Author
Comparative
Rsv
ATP
Drug Discovery
Ohio
Marketing
New Concepts
SOW
Project Planning
SAP XI
Lockheed Martin
Measurements
Contractual Agreements
Pharmacy
Indications
Genetics
Classroom
Reg
Electro
Compensation
Covering
Presentations
Fellowships
Iowa
Lexicon
LinkedIn
Pdf
Websites
Responsibility
DP
Amsterdam
Therapists
Regulations
International
Small Molecules
Lead Development
Biology
Renaissance
Magazines
ELISA
History
Curriculum Design
Start Ups
Teaching
Milestone
Reviews
Grants
ICH guidelines
Academic
SCI Clearance
Disclosure
Diagnostics
Subsidiaries
Expansions
Energetics
San Diego
Concerts
Compliance
Business Planning
Animal Work
Muscle Physiology
Proposal Writing
Pharmaceutics
Manufacturing
In Vitro
Gene Regulation
Platforms
Lamb
Pharmacoeconomics
Formulation
Open Access
Scientists
Due Diligence
Infection
Tolerance
Conceptual Modeling
Meetings
Technology Platforms
Summit
Mergers and Acquisitions
Electrophoresis
Delivery
Polymorphism
Diabetic
Unified Communications
Insect
Bridge
Bioscience
NMR
FDA
Strength Training
Competition
North American
Phosphate
Global Alliance Management
Record of Success
Negotiation
In Licensing
In/Out Licensing
Strategic Alliances

Dan Shelly Summary

Dan Shelly, based in Cincinnati, OH, US, is currently a Chief Business Development Officer at Immuthera. Dan Shelly brings experience from previous roles at PolTREG S.A., BioSolution Designs, BioStem Technologies (OTC: BSEM) and Prescient Therapeutics. Dan Shelly holds a 2000 - 2002 MBA in Innovation @ University of Cincinnati Carl H. Lindner College of Business. With a robust skill set that includes Biotechnology, Biopharmaceuticals, Life Sciences, Lifesciences, Vaccines and more. Dan Shelly has 4 emails and 1 mobile phone numbers on RocketReach.